top
Search terms
Results 1 - 4 of 4 - ordered by :
Ehjournal

Abstract Aims Although non-vitamin K antagonist oral anticoagulants are recommended for stroke prevention in patients with non-valvular atrial fibrillation (NVAF) based on clinical trial results, ...

European Heart Journal, FASTTRACK ESC Clinical Registry, A. John Camm, Pierre Amarenco, Sylvia Haas, Susanne Hess, Paulus Kirchhof, Silvia Kuhls, Martin van Eickels, Alexander G.G. Turpie

Date : 07/04/2016 Item size : 258982 bytes
Epeuropace

Abstract Aims We sought to describe the management of patients with atrial fibrillation (AF) in Europe after the release of the 2010 AF Guidelines of the European Society of Cardiology. Oral ...

Europace, Atrial fibrillation, Paulus Kirchhof, Bettina Ammentorp, Harald Darius, Raffaele De Caterina, Jean-Yves Le Heuzey, Richard John Schilling, Josef Schmitt, Jose Luis Zamorano

Date : 01/01/2014 Item size : 264702 bytes
Ehjournal

Abstract Aims X-VeRT is the first prospective randomized trial of a novel oral anticoagulant in patients with atrial fibrillation undergoing elective cardioversion. Methods and results We assigned ...

European Heart Journal, ESC Hot Line Barcelona, Riccardo Cappato, Michael D. Ezekowitz, Allan L. Klein, A. John Camm, Chang-Sheng Ma, Jean-Yves Le Heuzey, Mario Talajic, Maurício Scanavacca, Panos ...

Date : 14/12/2014
Epeuropace

All published studies have shown that rate control is not inferior to rhythm control for the prevention of mortality and morbidity (Tables 1 and 2).612 This disappointing outcome may relate to the ...

Europace, Review, Isabelle C. Van Gelder, Laurent M. Haegeli, Axel Brandes, Hein Heidbuchel, Etienne Aliot, Josef Kautzner, Lukasz Szumowski, Lluis Mont, John Morgan, Stephan Willems, Sakis ...

Date : 01/11/2011